Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fractyl Health (GUTS) Cost of Revenue (2023 - 2024)

Fractyl Health (GUTS) has disclosed Cost of Revenue for 2 consecutive years, with $7000.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Cost of Revenue fell 72.0% year-over-year to $7000.0, compared with a TTM value of $50000.0 through Dec 2024, down 35.06%, and an annual FY2024 reading of $50000.0, down 35.06% over the prior year.
  • Cost of Revenue was $7000.0 for Q3 2024 at Fractyl Health, down from $24000.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $47000.0 in Q2 2023 and bottomed at $2000.0 in Q4 2023.